Clinical Chemistry · 2006 · 39 citations · 27 references
MedicineCardiologyObstetricsClinical ImmunologyImmunopathologyMonoclonal AntibodiesAntibody CharacterizationDiagnostic Antibody ApplicationsAcute Coronary Syndrome BiomarkersAntibodiesCapture Antibody SelectionDouble Antibody Sandwich AssaysMaternal AntibodiesMonoclonal Antibody Selection
BACKGROUND: Pregnancy-associated plasma protein-A (PAPP-A) concentrations are increased in the circulation of patients with acute coronary syndromes (ACS) and are associated with future adverse cardiac events. PAPP-A in ACS differs from PAPP-A in pregnancy in that PAPP-A in ACS is not complexed with the proform of eosinophil major basic protein (proMBP). We investigated the effect of antibody selection on the utility of PAPP-A assays for measurement of PAPP-A in pregnancy and/or ACS, and whether immunoassays for PAPP-A in pregnancy are suitable for PAPP-A in ACS. METHODS: We constructed 2-site sandwich time-resolved immunofluorometric assays using 22 monoclonal antibodies raised against pregnancy serum PAPP-A. All antibodies were studied in pairs, with each antibody used as either capture or tracer. We compared the reactivity of each antibody combination with PAPP-A/proMBP complex derived from pregnancy sera or with uncomplexed PAPP-A extracted from atherosclerotic plaques. Recombinant human PAPP-A and proMBP were also used to determine the specificity of the antibodies. We confirmed all major findings with serum samples collected from patients with myocardial infarction. RESULTS: Six monoclonal antibodies reacted with the proMBP subunit of the PAPP-A/proMBP complex. Epitopes of 3 proMBP-reactive antibodies largely overlapped, but were well separated from those of another group of 3 proMBP-reactive antibodies. Assays using any of the 6 proMBP-reactive antibodies failed to detect PAPP-A in ACS. In addition, some 2-site assays capable of detecting PAPP-A in pregnancy were almost incapable of detecting PAPP-A in ACS, although the individual epitopes remained detectable in PAPP-A in ACS. CONCLUSIONS: Immunoassays developed for PAPP-A in pregnancy may not be suitable for PAPP-A in ACS. Assays for PAPP-A in ACS should be based on careful antibody selection and subjected to extensive testing with clinical ACS samples.
27
First-Trimester Screening for Trisomies 21 and 18
Ronald J. Wapner, Elizabeth Thom, Joe Leigh Simpson et al. · New England Journal of Medicine · 2003 · 567 citations · Full text
Medicine, Genetics, Obstetrics +17
David Krantz, Laura Goetzl, Joe Leigh Simpson et al. · American Journal of Obstetrics and Gynecology · 2004 · 285 citations